PTPRC and neoplasm: Following the dissociation of fresh tumor samples, TO-PRO-3−EpCAM+CD45− viable tumor epithelial cells (hereafter referred to as the tumor cell fraction) and TO-PRO-3−EpCAM−CD45+ viable immune cells (hereafter referred to as the immune cell fraction) were sorted using flow cytometry (Figure 1).